Mixed options sentiment in ImmunityBio (IBRX), with shares up 51c, or 6.88%, near $7.92. Options volume roughly in line with average with 25k contracts traded and calls leading puts for a put/call ratio of 0.22, compared to a typical level near 0.31. Implied volatility (IV30) dropped 0.87 near 128.2,in the top quartile of the past year, suggesting an expected daily move of $0.64. Put-call skew steepened, indicating increased demand for downside protection.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IBRX:
- “FDA Warning” on Cancer Drug Sends ImmunityBio Stock (IBRX) Tumbling over 26%
- ImmunityBio’s FDA warning letter doesn’t change fundamentals, says BTIG
- ImmunityBio falls -26.4%
- Midday Fly By: Estee Lauder in deal talks with Puig, Smithfield reports Q4 beat
- Option traders moderately bearish in ImmunityBio with shares down 22.61%